[1] 古川, 徐小元, 熊辉. 肝硬化食管胃静脉曲张的一级预防和二级预防. 实用肝脏病杂志, 2016, 19(5):513-515. [2] Seo YS . Prevention and management of gastroesophageal varices. Clin Mol Hepatol, 2018, 24(1):20-42. [3] Jakab SS, Garcia-Tsao G. Evaluation and management of esophageal and gastric varices in patients with cirrhosis. Clin Liver Dis, 2020, 24(3):335-350. [4] Lenzen H , Musmann E, Kottas M , et al. Acute gastrointestinal bleeding cases presenting to the emergency department are associated with age, sex and seasonal and circadian factors. Eur J Gastroenterol Hepatol, 2017, 29(1):78-83. [5] 肖勇, 于红刚, 陈明锴. 肝硬化门静脉高压食管胃静脉曲张出血的内镜诊治策略. 中华消化内镜杂志, 2018, 35(2):84-88. [6] Kim BK, Han KH, Park JY, et al. A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis. Am J Gastroenterol, 2010, 105(6):1382-1390. [7] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南(2015年版). 实用肝脏病杂志, 2016, 19(3):Ⅴ-ⅩⅩⅢ. [8] 刘成海, 危北海, 姚树坤. 肝硬化中西医结合诊疗共识. 中国中西医结合杂志, 2011, 19(4):277-279. [9] 武金玉, 陈敏华, 戴莹,等. 超声对肝纤维化和肝硬化半定量诊断探讨-肝被膜形态及肝内韧带观察. 中华超声杂志, 2003, 12(8):478-481. [10] 杨晴, 刘东屏, 李鲁平,等. 慢性乙型肝炎肝纤维化非创伤性诊断模型的建立与评价. 中华肝脏病杂志, 2017, 25(1):15-20. [11] Zhang GM, Xia YJ. Reference intervals of fibrosis index based on four indicators in healthy elderly Chinese. J Clin Lab Anal, 2016, 30(5):645-648. [12] 中华医学会肝病学分会、消化病学分会、内镜学分会. 肝硬化门静脉高压食管胃静脉曲张出血的防治指南. 实用肝脏病杂志, 2016, 19(5):Ⅰ-ⅩⅤⅠ. [13] 王春妍, 蒋贝, 李嘉,等. 超声内镜对肝硬化患者胃食管静脉曲张早期诊断价值的评估. 中华肝脏病杂志, 2016, 24(9):671-675. [14] Mathur SK, Shah SR, Soonawala ZF, et al. Transabdominal extensive oesophagogastric devascularization with gastro-oesophageal stapling in the management of acute variceal bleeding. Br J Surg, 2015, 84(3):413-417. [15] Bintintan A, Chira RI, Mircea PA. Non-invasive ultrasound-based diagnosis and staging of esophageal varices in liver cirrhosis. a systematic review of the literature published in the third millenium. Med Ultrason, 2013, 15(2):116-124. [16] 魏华, 马旭艳. 彩色多普勒超声半定量评分对早期乙型肝炎肝硬化的诊断价值. 实用肝脏病杂志, 2017, 20(1):78-80. [17] 林诗彬, 郑恩海, 杨克丰,等. 彩色多普勒超声检查对乙型肝炎肝硬化患者食管静脉曲张预测价值分析. 实用肝脏病杂志, 2019, 22(3):409-412. [18] Lurie Y, Webb M, Cytter-Kuint R, et al. Non-invasive diagnosis of liver fibrosis and cirrhosis. World J Gastroenterol, 2015, 21(41):11567-1183. [19] Karanjia RN, Crossey MM, Cox IJ, et al. Hepatic steatosis and fibrosis: Non-invasive assessment. World J Gastroenterol, 2016, 22(45):9880-9897. [20] Jakab SS, Garcia-Tsao G. Evaluation and management of esophageal and gastric varices in patients with cirrhosis. Clin Liver Dis, 2020, 24(3):335-350. [21] Mooney P, Hayes P, Smith K. The putative use of alpha-1-acid glycoprotein as a non-invasive marker of fibrosis. Biomed Chromatogr, 2006, 20(12):1351-1358. [22] Yin Z, Zou J, Li Q, et al. Diagnostic value of FIB-4 for liver fibrosis in patients with hepatitis B:a meta- analysis of diagnostic test. Oncotarget, 2017, 8(14):22944-22953. [23] 李娜, 郑少秋, 赵守松. FibroScan联合多种预测模型预测肝硬化患者食管静脉曲张程度应用价值探讨. 实用肝脏病杂志, 2020, 23(4):560-563. |